What Happens During a Glaucoma Consultation?

A glaucoma consultation in my clinic follows a structured five-step process. Detailed history and vision assessment, comprehensive eye examination, glaucoma-specific testing (including corneal thickness, eye pressure, gonioscopy, OCT, and visual fields when needed), pupil dilation if required, and a personalized discussion of findings.

Every consultation ends with practical education on how to use eye drops correctly and simple strategies to improve treatment adherence. Successful glaucoma care depends on both accurate diagnosis and consistent treatment.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

What Happens During a Glaucoma Consultation? A Doctor’s Walkthrough

Most patients walk into a glaucoma consult expecting a quick pressure check and a prescription. What they get instead, in my clinic, is a sequence. History, vision, anterior segment, a deliberate order of imaging and gonioscopy, baseline pressure testing across more than one visit. The final ten minutes that I consider non negotiable, teaching you how to actually use your drops.

I have refined this sequence over years of glaucoma practice because the disease itself demands it. You cannot feel your eye pressure changing. You cannot feel your nerve fibre layer thinning. The only way to catch glaucoma early and keep it from progressing is a structured, repeatable, slightly unglamorous process. Repeated the same way every single time.

This page walks through that process exactly as it happens in my clinic. So that you know what to expect. It also helps you plan your day better.

Quick Answer: A glaucoma consultation in my clinic moves through five stages. First, the optometrist takes a detailed history and checks vision. This includes uncorrected vision, best corrected vision, and vision with your current glasses. Second, I review that history myself and examine the front of your eye. Third, I run structural and functional tests in a specific order. Corneal thickness, then pressure measurement, then gonioscopy, with OCT and visual field testing done before gonioscopy when they are needed. Fourth, if your pupils need to be dilated, you wait about forty five minutes. Fifth, no consult ends without me personally teaching you how to instil your eye drops correctly and how to remember whether you have taken them.

Dr Shibal Bhartiya Gurgaon glaucoma consultation infographic showing diagnostic testing and treatment pathway steps; navigating glaucoma consultation — A look inside a real glaucoma consultation with Dr Shibal Bhartiya in Gurgaon: structured testing order, baseline pressure checks across visits, and personalised target pressure zones that guide treatment decisions before any drop is prescribed.

Step 1: Before You See Me, the Optometrist Does the Groundwork

Every consult starts with my optometrist, not with me. This is deliberate. It means your history is captured properly and your vision is measured in a structured way before I ever walk into the room.

History taking

The optometrist takes a detailed history and reviews any prior reports, scans, or visual fields you bring with you, noting all of it into your file. This includes systemic conditions that have nothing to do with the eye on the surface, diabetes, high blood pressure, heart disease, asthma, or autoimmune disease, along with any current medications and known allergies. Glaucoma management decisions are frequently shaped by what is happening in the rest of your body, so none of this is skipped.

Three vision measurements, not one

Your vision is then checked through a formal refraction, and three separate numbers are recorded:

UCVA, your uncorrected visual acuity, what you see with no glasses at all
PGP, your vision with the glasses you are currently wearing and prescribed
BCVA, your best corrected visual acuity, what you could see with the ideal glasses prescription

Comparing these three numbers tells me whether a vision problem is about your eyewear, your ocular surface, or your optic nerve, before I have even examined you. A non contact tonometry pressure check is occasionally done at this stage as a screening step. I insist on Goldmann Applanation Tonometry for all of my glaucoma patients.

Step 2: I Review Your History and Examine the Front of the Eye

When you come in to see me, I read through everything the optometrist has documented at a glance. If anything looks incomplete, inconsistent, or worth a second look, I will ask more specific questions to understand it properly before moving forward.

There is also, always, a few minutes of ordinary conversation. A glaucoma consult is a long term relationship, not a transaction. It starts with treating you like a person before a set of test results. And you will be shocked at the details I remember. Your family, your last vacation, your dog 🙂 sometimes, even your favourite chutney!

I then examine the front of your eye in detail. The conjunctiva and ocular surface, the meibomian glands, the eyelid and bulbar conjunctiva, the anterior chamber, and the lens, looking specifically for cataract, a shallow anterior chamber, or any cells in the anterior chamber (inflammation).

Step 3: A Deliberate Order of Testing, Not a Random Checklist

The sequence in which glaucoma tests are performed matters, and I follow a fixed order rather than doing whichever test is most convenient.

Angle assessment first, with imaging informing the decision

I assess the optic nerve with a 90 dioptre lens. Every glaucoma patient gets a gonioscopy. When you need a repeat gonioscopy is decided after that. I perform it only after the visual field test, the OCT, and fundus photography are done, when those are part of that visit. Imaging the nerve and the visual field before manipulating the angle gives me a cleaner functional and structural baseline to work from.

Central corneal thickness, then pressure, then gonioscopy

Before gonioscopy, I measure central corneal thickness (CCT), the test also called pachymetry. Corneal thickness directly affects how your raw eye pressure reading should be interpreted. But it is always done before your tonometry. Because touching your corneas to measure your IOP before the CCT may alter it slightly. Gonioscopy then follows. This examines your drainage angle under magnification. This determines whether you have an open angle or a narrow angle profile.

Why I do the pressure check myself

Goldmann applanation tonometry (GAT), the test that measures your intraocular pressure, is the one test I do not delegate. In my clinic, I personally perform this for every glaucoma patient before treatment starts. Again at the first follow up, and at every annual review. My optometrists are trained to do it and do perform it in my absence. Doing it myself gives me a direct feel for what is happening in your eye that a number on a chart cannot fully convey.

I also insist on doing my gonioscopy myself, always with the lights switched off, so be prepared for a few minutes in a dark room. I keep talking to you, so its never scary.

How is Applanation Tonometry Done?

For the GAT, one of my team members will put some numbing eyedrops and ask you not to touch your eye. I then put a dye which stains your tears yellow. And then I check your eye pressures under blue light on the slit lamp, with a prism that comes close to the eye.

It takes less than a minute if you don’t blink and keep looking straight ahead, and a few extra seconds if you fidget. It’s painless, and quick, and we finish with a drop of antibiotic in the eye.

Step 4: Dilation, When It Is Needed

If your assessment requires dilating your pupils, you will be told this in advance, because dilation takes about forty five minutes to take full effect and changes how you experience the rest of your day.

We ask you to bring dark glasses, a scarf, or an umbrella, since dilated eyes are far more light sensitive, particularly in Gurugram’s daytime heat
We advise you not to drive yourself home after a dilated examination

Step 5: Establishing a True Baseline, Not a Single Snapshot

Glaucoma decisions should never rest on one reading taken on one day. Two specific habits in my clinic exist to correct for that.

Repeating your first visual field

There is a genuine learning curve to taking a visual field test well. The first attempt is frequently unreliable simply because the patient has not yet learned the rhythm of the test. I routinely discard the first visual field and ask patients to return the next morning. We do not charge for that repeat test. The inaccuracy is a known limitation of the test itself, and is not a reason to bill twice.

Three pressure readings, not one

For a true baseline, I usually take three intraocular pressure readings at different times of day. Rather than relying on a single number, since pressure naturally fluctuates through the day. One of these three readings may be taken by an optometrist, if it’s after my working hours. We usually work from the average of all three.

The water drinking test

A formal diurnal variation test, in which pressure is measured every few hours through the day, is not practical for every patient. We often use the water drinking test as a more practical stand in. This is typically done before starting treatment, again about one to two months after treatment begins. We may repeat it if your eye appears to be progressing despite your pressure meeting its target.

Step 6: Setting Your Personalised Target Pressure

There is no single universal normal pressure number in modern glaucoma care. Your corneal thickness, the structure of your drainage angle, and your Visual field and OCT baseline are combined to calculate a target pressure zone. This is specific to your eye, designed to halt progression for you.

Step 7: The Most Important Section of Glaucoma Consultation: Eye Drop Training

A prescription on its own does not protect your vision if the drops never go in correctly or are forgotten. So every consult ends with practical training, not just instructions.

I personally show you how to instil your eye drops correctly, since technique affects how much medication actually reaches the eye
I ask you to set a phone alarm for every dose. Because relying on memory alone is the most common reason treatment fails
If you are on more than one medication, I recommend keeping two small boxes. One empty and one full of your drop bottles. After each dose, you move that bottle from the full box to the empty one. So a glance at the boxes tells you whether you have already taken that round of drops. And which ones remain.
When you leave, my coordinator helps you set your next appointment, before you leave the clinic. You will also receive a Whatsapp message with links to important information and details of phone numbers to book appointments. You will also get my direct phone number for any clinical queries, or emergencies.

When To See Me Before Your Booked Glaucoma Consultation

Sudden eye pain, redness, or blurred vision, which can signal an acute angle closure attack
Any one sided change in vision or eye appearance
Headache or nausea accompanying eye pain
A noticeable change in your visual field between scheduled visits
New side effects after starting or changing a glaucoma medication
Missed doses for several consecutive days, which should be flagged at your next visit rather than left unmentioned

This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?

Frequently Asked Questions

Why does the optometrist see me before the doctor does?

The optometrist’s workup, history, refraction, and the three part vision check, ensures your file is complete and your baseline vision is documented accurately before I begin my own examination. This makes the time I spend with you more focused on interpretation and decision making rather than data collection.

Why do you measure my eye pressure yourself instead of leaving it to staff?

Goldmann applanation tonometry is the gold standard pressure test, and for every glaucoma patient I treat, I perform it myself before starting treatment, at the first follow up, and at every annual review. It gives me a direct sense of your eye’s behaviour that I do not want to lose by always delegating it.

Why do you discard my first visual field test and ask me to repeat it?

Most patients have not yet learned the rhythm of the visual field test on their first attempt. This makes that first result unreliable. We ask you to return the next morning for a repeat test. We do not charge for it, since the inaccuracy belongs to the learning curve of the test, not to you.

Why is gonioscopy done after OCT and visual field testing, not before?

When OCT, visual field testing, and fundus photography are part of your visit, I prefer to have that structural and functional picture in hand before manipulating the angle during gonioscopy. The order is chosen to give the cleanest possible baseline. Also, sometimes I use a viscoelastic gel for gonioscopy. In that case, your vision is fuzzy for about ten minutes after, and I don’t want your time wasted.

What is the water drinking test and why would I need one?

It is a practical way of checking how your eye pressure responds to a physiological stress. This is used in place of round the clock diurnal variation testing, which is not feasible for every patient. I typically use it before starting treatment. I may repeat it again a month or two into treatment. And again later if your eye appears to be progressing even though your pressure looks controlled.

Why do you spend time teaching me to put in my own eye drops?

Technique directly affects how much medication reaches your eye. A missed or mistimed dose is the most common reason glaucoma treatment underperforms. Pairing a phone alarm with the two box system is simple. It gives you a simple, visual way to know whether today’s dose has already gone in. Research says it is the most important intervention in preventing glaucoma blindness.

Key Takeaways

Your consult begins with the optometrist. They document history and perform three vision measurements, UCVA, PGP, and BCVA, before I examine you
Testing follows a fixed order: imaging and visual field first when needed, then corneal thickness, then gonioscopy, then pressure measurement
I personally measure your eye pressure for every glaucoma patient at key visits, rather than delegating it
Your first visual field is usually repeated free of charge, because of a genuine learning curve with the test
Baseline pressure is built from three readings at different times of day, sometimes supplemented by a water drinking test
Your target pressure is personalised to your eye’s anatomy, not based on one generic normal number
No consult ends without hands on training in how to use your drops. And how to track whether you have taken them

Book a Consultation

If you have been told you have glaucoma, or are due for a routine check because of family history or elevated pressure, this is the process you can expect to walk through.

[Book an Appointment →www.drshibalbhartiya.com | +91 88826 38735]

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

A Routine Eye Check and Glaucoma

A routine eye check may raise suspicion of glaucoma through elevated eye pressure, changes in the optic nerve, or unexplained vision changes. However, confirming glaucoma usually requires specialised tests such as optic nerve imaging, visual field testing, and corneal thickness measurement. Also, a routine for glasses is not a substitute for an eye exam, as the former can often miss glaucoma.

Glaucoma usually causes no pain, no redness, and no obvious vision change in its early stages. Most people with glaucoma feel completely normal until significant and irreversible damage has occurred. The only way to detect it early is a comprehensive eye examination that includes optic nerve assessment, intraocular pressure measurement, and visual field testing

A Routine Eye Check Revealed a Sight-Threatening Disease

Mrs SG came to see me because her glasses prescription had not felt right for a few months. She was 57. She worked at a desk. Her eyes were tired by evening, and she assumed she needed a stronger number. She had no pain. No redness. No alarming moment that made her think something was wrong.

Her previous optician had given her a new prescription six months earlier. It had not helped. She booked an appointment with me because a colleague had suggested a second opinion.

I examined her in the usual way. Her visual acuity was reasonable. Her anterior segment was quiet. Then I checked her retina and optic nerve.

The optic nerve in her left eye had a cup that was too large. The rim tissue was thinning at the inferior pole. Her intraocular pressure was 24 mmHg in the right eye and 26 in the left. I asked her to sit with the visual field machine.

The field test confirmed what the disc had suggested. There was a dense arcuate defect in her left eye. A significant portion of her peripheral vision was already gone. She had not noticed. You rarely do with glaucoma, because the brain fills in the gaps until it cannot.

She did not need a stronger glasses prescription. She had glaucoma, and it had been quietly advancing for what was likely several years.

Patient details have been changed to protect privacy.

Remember

Sunita’s case is not unusual. Glaucoma is called the silent thief of sight for a reason. It causes no pain, no visible redness, and no early warning that most patients would recognise. By the time vision loss is noticeable, the disease has already caused permanent damage. In India, an estimated 12 million people have glaucoma, and almost 90% of them do not know it. (The Chennai glaucoma Study).

Below, I explain what glaucoma actually does to the eye, why it is so reliably missed, and which symptoms, or absences of symptoms, should prompt an urgent examination.

What Glaucoma Actually Does to Your Eye

Glaucoma is a disease of the optic nerve. The optic nerve carries visual information from the eye to the brain. When this nerve is damaged, that information is lost permanently. No treatment can restore what is already gone. Treatment can only slow or stop further damage.

In most cases, the damage is caused or worsened by raised pressure inside the eye. This pressure, called intraocular pressure or IOP, builds when fluid inside the eye does not drain properly. The drainage system becomes less efficient over time, pressure rises, and the optic nerve fibres begin to die. The process is painless in the vast majority of patients.

What makes glaucoma particularly deceptive is the pattern of vision loss. It begins at the periphery, the edges of your visual field. The brain compensates automatically. Both eyes together create a complete picture, and each eye covers for the blind spots of the other. Patients often do not notice peripheral vision loss until more than 40 percent of their optic nerve fibres have already been destroyed. By that point, the disease is well advanced.

In SG’s case, her glasses prescription had changed slightly because her visual system was compensating for early field loss. It was not a refractive change. It was her brain working harder to make sense of incomplete information. This pattern, subtle visual dissatisfaction without a clear cause, is one of the most common presentations I see in patients who turn out to have early to moderate glaucoma.

Glaucoma vs Normal Ageing: How to Tell the Difference

Symptom or Sign	What It Suggests	What To Do
Gradual blurring that a new glasses prescription does not fix	May indicate optic nerve or macular pathology, not refractive change	See an ophthalmologist for optic nerve assessment, not just a refraction
Difficulty adjusting from bright to dim light	Can be an early sign of peripheral field loss	Request a visual field test at your next eye appointment
Frequent glasses changes with no lasting improvement	Suggests the problem is not the prescription	Ask for intraocular pressure measurement and disc evaluation
Mild headache or eye heaviness without redness	In some patients, mildly elevated IOP causes subtle discomfort	Check IOP, especially if over 40 or with family history of glaucoma
No symptoms at all, but a family member has glaucoma	First-degree relatives have a 4 to 9 times higher risk	Schedule a comprehensive glaucoma screening even if you feel completely well
Squinting or tilting the head to see clearly	May indicate undetected visual field asymmetry	Full field test for both eyes separately

Why Glaucoma Is So Often Missed

The most common reason glaucoma goes undetected is that a routine glasses check is not a glaucoma examination.

When a patient visits an optician or a basic eye clinic for a new prescription, the standard assessment measures visual acuity and refraction. It does not always include optic nerve photography, intraocular pressure measurement, or visual field testing. These are the three investigations that detect glaucoma. Without all three, the disease is invisible.

Sunita had seen an optician twice in three years. Her visual acuity was checked each time. Her optic nerve was never examined.

The second reason glaucoma is missed is the absence of symptoms. Patients present to doctors when something feels wrong. Glaucoma does not feel wrong, not for years. There is no cultural expectation in India of an annual comprehensive eye examination. Most people attend only when they need a new prescription or when something is visibly red or painful. By those criteria, a glaucoma patient has no reason to come at all.

The third reason is that IOP alone is not a reliable screening tool. Many patients with glaucoma have pressure in the so-called normal range. Normal-tension glaucoma accounts for a substantial proportion of cases, particularly in people of Asian descent. A single IOP reading of 16 mmHg does not exclude the diagnosis.

SG’s IOP was elevated, which made diagnosis more straightforward. But many of my patients with confirmed glaucoma have had pressures that would not have triggered concern at a routine check.

When To See an Eye Specialist

See an ophthalmologist for a comprehensive glaucoma assessment if any of the following apply:

A parent, sibling, or child has been diagnosed with glaucoma
You are over 40 and have not had a comprehensive eye examination in the past two years
You have been told your eye pressure is “a little high” but were not referred further
You have changed your glasses prescription twice in two years with no lasting improvement
You have diabetes, as this increases glaucoma risk
You are of South Asian, East Asian, or African descent, all of which carry higher glaucoma risk
You use steroid eye drops, nasal sprays, or inhalers long-term
You were told everything was fine, but your vision still does not feel right

A comprehensive assessment takes around 30 to 45 minutes and is painless. It will include optic nerve imaging, IOP measurement, corneal thickness assessment, and a visual field test. This combination reliably detects glaucoma at a stage when treatment can prevent significant vision loss.

Frequently Asked Questions

Can you have glaucoma with normal eye pressure?

Yes. Normal-tension glaucoma is a recognised and common form of the disease, particularly in people of Asian descent. A normal IOP reading does not rule out glaucoma; optic nerve assessment and visual field testing are essential.

Does glaucoma always cause pain?

No. The most common forms of glaucoma are completely painless. Pain is associated with acute angle-closure glaucoma, which is a sudden and rare presentation. Most patients with chronic open-angle glaucoma, the most prevalent type, feel nothing at all until vision loss is advanced.

Can lost vision from glaucoma be restored?

No. Optic nerve damage caused by glaucoma is permanent. Treatment with eye drops, laser, or surgery can slow or stop further damage, but vision already lost cannot be recovered. Early detection is the only way to protect useful sight.

How often should I have a glaucoma check if I have a family history?

If a first-degree relative has glaucoma, you should have a comprehensive eye examination every year from the age of 40, or earlier if your ophthalmologist advises it.

Book a Consultation

If you have a family history of glaucoma, have not had a comprehensive eye examination in the past two years, or have been told your eye pressure is elevated, a dedicated assessment is worth arranging now. The earlier glaucoma is found, the more vision can be protected.

At Dr Shibal Bhartiya Eye Clinic, Gurugram, a glaucoma assessment includes optic nerve imaging, visual field testing, corneal thickness measurement, and a full review of your risk profile. [second opinion]

[Book an Appointment → +91 88826 38735]

This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Common Myths About Glaucoma

Most common myth about glaucoma is that it causes pain or obvious vision loss, but early glaucoma is often silent and progresses slowly. Regular eye examinations are important because glaucoma damage can occur long before symptoms become noticeable.
Patients who believe they would notice symptoms, that only older people are affected, or that treatment means surgery are the patients who present late. Here is what is true, explains Dr Shibal Bhartiya.

Glaucoma affects over 12 million people in India. The majority do not know they have it. Part of the reason is the disease itself: silent, slow, and peripheral. But part of the reason is misinformation that creates false reassurance at precisely the moment awareness matters most.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Eight Glaucoma Myths That Cost People Their Vision

Myth	What the Evidence Shows
Glaucoma only affects the elderly.	While risk rises with age, glaucoma can occur at any age. Juvenile glaucoma affects teenagers. Primary open angle glaucoma is well documented in patients in their 30s and 40s, particularly in South Asian populations with high myopia or family history.
I would know if I had glaucoma — my vision is fine.	Glaucoma destroys peripheral vision first. Central vision — what you use to read and recognise faces — is preserved until very late in the disease. The brain compensates for peripheral loss so effectively that patients can lose 40% of their optic nerve before noticing anything.
Glaucoma always causes high eye pressure.	Normal tension glaucoma — where the optic nerve is damaged despite normal IOP — accounts for 30–40% of glaucoma in India. A normal pressure reading does not mean your optic nerve is safe.
Glaucoma means I will go blind.	Glaucoma diagnosed and treated early is very unlikely to cause blindness. Most patients with well-managed glaucoma retain functional vision for life. The blindness associated with glaucoma is almost always the result of late detection or inadequate treatment.
Glaucoma treatment means surgery.	The majority of glaucoma patients are managed with eye drops alone for many years. Laser procedures (SLT) are used when drops are insufficient or poorly tolerated. Surgery is reserved for cases where other treatments fail or where IOP needs to be lowered substantially.
Once I start glaucoma drops, I am on them forever.	Treatment duration depends on the stage of disease, IOP response, and patient factors. Some patients transition from drops to laser. Some achieve adequate control with laser alone. Surgical treatment can reduce or eliminate drop dependence. Your specialist reviews this regularly.
Glaucoma runs in my family but I feel fine, so I must be fine.	Family history of glaucoma increases your personal risk four to nine times. Feeling fine is expected — glaucoma is asymptomatic. A first-degree relative with glaucoma is the single strongest indication for annual specialist screening, regardless of how well you feel.
Glaucoma eye drops are just for reducing pressure — they have no other effect.	Glaucoma drops significantly affect the eye surface, causing dry eye, redness, and allergic reactions in many patients. Some systemic drops affect heart rate and blood pressure. Your specialist needs to know your full medical history and all medications before prescribing.

Frequently Asked Questions

Is There a Cure for Glaucoma?

There is no cure for glaucoma in the sense of restoring damaged nerve tissue. The optic nerve fibres lost to glaucoma do not regenerate. Treatment halts or slows progression — it does not reverse what has already been lost. This is why early detection is the single most important determinant of outcome.

Can I Check My Own Eye Pressure at Home?

Home tonometers are available and improving, but they are not a substitute for specialist monitoring. IOP is one variable in glaucoma management. Optic nerve appearance, visual field status, and nerve fibre layer thickness are equally or more important — none of which a home device measures. Home monitoring may have a role as a supplement to specialist care, not a replacement for it.

How Often Do I Need to See a Glaucoma Specialist?

This depends on your disease stage and stability. Newly diagnosed or unstable patients are typically reviewed every three to four months. Stable patients with well-controlled IOP and no progression may be reviewed every six to twelve months. Your schedule is set by your specialist and should not be deferred because you feel well.

Does Glaucoma Affect Both Eyes Equally?

Glaucoma is often asymmetric — it begins in one eye before the other and progresses at different rates. This asymmetry is one reason patients do not notice it. The better eye compensates for the worse eye. By the time both eyes are significantly affected, the window for prevention has often closed in the first eye.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Related Reading
Get an Online Glaucoma Consult
Visual Field and OCT: Structure & Function Correlation
Glaucoma Diagnosis in Gurgaon
Risk Stratification in Glaucoma
Glaucoma Progression: What It Means and How to Slow It
Glaucoma treatment in Gurgaon
All About Glaucoma Medication
Glaucoma Lasers: SLT & LPI
Glaucoma surgery in Gurgaon
MIGS in Gurgaon
Get a Glaucoma Second Opinion in Gurgaon

Glaucoma and Dry Eye

Dry eye disease and glaucoma often occur together, especially because some glaucoma eye drops can affect the tear film and make symptoms like burning, irritation, watering, or fluctuating vision worse. Early diagnosis and treatment of both conditions can improve comfort and help protect long-term vision.

Glaucoma and dry eye disease occur together more often than chance alone explains. If your eyes burn, sting, or feel gritty while you are on glaucoma drops, you are not imagining it. This combination is common, clinically important, and often undertreated.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

How Common Is Glaucoma and Dry Eye Overlap?

Studies consistently show that 40 to 60 percent of glaucoma patients meet diagnostic criteria for dry eye disease. The reverse is also true: people with moderate to severe dry eye carry a higher risk of developing glaucoma-related damage. These are not coincidental companions. They share biological mechanisms, and each condition can quietly worsen the other.

Why Does Dry Eye Develop in Glaucoma Patients?

The preservative problem

Most glaucoma eye drops contain benzalkonium chloride (BAK) as a preservative. BAK is effective at keeping the bottle sterile, but it is toxic to the cells of the ocular surface. It disrupts the tear film, damages goblet cells (the cells that produce the mucin layer of your tears), and triggers chronic inflammation.

Patients who use two or three glaucoma drops daily — each containing BAK — are exposing their eyes to this preservative four, six, or more times every day. Over months and years, the cumulative damage is significant. The conjunctiva becomes inflamed, the cornea loses its smooth optical surface, and the eyes feel perpetually uncomfortable.

This is not a rare side effect. It is an expected biological consequence of long-term BAK exposure, and it is one of the most underrecognised sources of glaucoma-related suffering.

Pre-existing risk

Dry eye disease is more common in the same demographic groups that develop glaucoma: older adults, women after menopause, and people with autoimmune conditions. Many patients arrive at a glaucoma diagnosis already carrying a degree of ocular surface disease. Adding BAK-containing drops to a compromised surface accelerates the damage.

Reduced blink rate

Glaucoma patients and patients with dry eye often share a common modern risk factor: prolonged screen use. Reduced blink rate during screen time is one of the fastest-growing contributors to evaporative dry eye, and it worsens the tolerance to topical medications.

Why Does This Overlap Matter Clinically?

Medication adherence

Dry eye makes glaucoma drops uncomfortable. Burning, stinging, and a sense of grittiness after instillation are among the most common reasons patients quietly reduce their drop frequency or stop altogether. This is rational behaviour in response to pain — but the result is uncontrolled intraocular pressure and silent glaucoma progression.

Treating dry eye is not a cosmetic afterthought. It is a strategy for protecting adherence, which protects the optic nerve.

Diagnostic accuracy

Dry eye causes variable intraocular pressure readings. Epithelial irregularity from a damaged ocular surface can affect tonometry (pressure measurement) and cause artificially high or variable readings. This creates noise in the data your glaucoma specialist depends on.

Similarly, a poor ocular surface causes artefacts in OCT scans and visual field tests. Blurring from unstable tear film produces dips and losses in visual field testing that mimic glaucoma progression. Distinguishing true nerve damage from tear-film artefact requires a clinician who is looking for both.

Quality of life

Glaucoma itself does not hurt and often produces no symptoms until late. But the treatment — the drops — can make patients miserable. Chronic ocular surface pain, light sensitivity, and fluctuating vision are quality-of-life burdens that patients often accept as inevitable. They are not inevitable.

How Do We Assess This in the Clinic?

A comprehensive evaluation for a glaucoma patient with ocular surface complaints includes:

Tear film assessment: Tear breakup time (TBUT) measures how quickly your tear film breaks apart after a blink. In dry eye, this is shortened.
Ocular surface staining: Fluorescein and lissamine green dyes reveal damaged cells on the cornea and conjunctiva.
Meibomian gland evaluation: Most dry eye in glaucoma patients is evaporative, caused by dysfunction of the oil-producing meibomian glands at the lid margins.
Symptom questionnaires: Validated tools like OSDI (Ocular Surface Disease Index) capture the patient experience beyond what the slit lamp shows.
Review of the current drop regimen: How many drops, which preservatives, how many times daily.

What Are the Management Options?

Switching to preservative-free formulations

This is often the single most impactful intervention. Preservative-free glaucoma drops deliver the same intraocular pressure-lowering effect without the chronic ocular surface toxicity. Multiple classes of glaucoma medication are now available in preservative-free formats: prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, and fixed-dose combinations.

The transition requires some planning — not all formulations are available in preservative-free versions in every market, and cost is a factor — but for patients with documented ocular surface disease, this is a clinically justified switch that most guidelines now support.

Fixed-dose combination drops

Instead of using two bottles separately (each with its own preservative load), a fixed-dose combination delivers two active ingredients in one drop. This halves the number of preservative exposures per day. For patients who genuinely need two active agents, this is a practical step even before moving to preservative-free options.

Treating the dry eye directly

Ocular surface disease responds to targeted treatment. The approach depends on the type and severity:

Artificial tears: Lubricating drops, preferably preservative-free, used consistently throughout the day. These dilute residual BAK, stabilise the tear film, and reduce surface friction.
Warm compresses and lid hygiene: For meibomian gland dysfunction, daily warm compress application followed by gentle lid massage improves the quality of the oily tear layer.
Omega-3 supplementation: Good evidence supports dietary omega-3 fatty acids for meibomian gland function and tear quality.
Anti-inflammatory therapy: Topical cyclosporine (Restasis, Ikervis) or lifitegrast addresses the inflammatory cycle that perpetuates chronic dry eye. In patients with significant ocular surface inflammation, this can be transformative.
Punctal plugs: Small silicone plugs inserted into the tear drainage points slow the drainage of natural tears, keeping the eye surface better hydrated.

Laser and surgical IOP control

For some patients, reducing or eliminating the need for topical drops altogether is the right goal. Selective laser trabeculoplasty (SLT) can lower IOP without any drops. For more advanced glaucoma, surgical options including minimally invasive glaucoma surgery (MIGS) and trabeculectomy may reduce drop burden significantly. When a patient’s ocular surface is severely compromised by long-term drop use, a surgical discussion is worth having.

A Note on Sequence and Timing

When a patient presents with both conditions, the sequence of assessment matters. Dry eye can artificially distort IOP readings and OCT quality. I prefer to stabilise the ocular surface first — or at least treat both simultaneously — so that subsequent glaucoma monitoring data is reliable. A visual field test performed through an unstable tear film is not a trustworthy test.

What Should You Tell Your Doctor?

If you are being treated for glaucoma and your eyes feel uncomfortable, please say so explicitly. Many patients assume irritation is part of the package and do not raise it. Your doctor needs to know:

Which symptoms bother you most (burning, grittiness, blurred vision, light sensitivity)
Whether symptoms are worse at certain times of day or after drop instillation
Whether you have ever reduced or skipped your drops because of discomfort
Whether you use a screen for extended hours daily

This information changes the clinical approach. It does not make you a difficult patient — it makes your care more precise.

Frequently Asked Questions

Can glaucoma drops cause dry eye?

Yes. Most glaucoma drops contain benzalkonium chloride, a preservative that damages the ocular surface over time. Long-term exposure causes inflammation, goblet cell loss, and dry eye disease. Switching to preservative-free formulations often brings significant relief.

Do I have to choose between treating my glaucoma and treating my dry eye?

No. Both conditions can and should be managed simultaneously. In many cases, treating dry eye actively improves the tolerability of glaucoma drops and supports adherence to treatment, which protects the optic nerve.

Are preservative-free glaucoma drops as effective as regular drops?

Yes. The active ingredient is the same. The preservative is only there to keep the bottle sterile between uses. Preservative-free formulations use single-dose units instead, delivering the same intraocular pressure-lowering effect without the surface toxicity.

Can dry eye affect my glaucoma test results?

Yes. An unstable tear film causes variable IOP readings and artefacts in visual field and OCT testing. This is one reason a thorough ocular surface assessment is part of comprehensive glaucoma care.

I use three different glaucoma drops. Is that a problem for my eyes?

Three separate bottles often means three doses of BAK per application. This is a significant preservative load. A conversation about fixed-dose combinations or preservative-free alternatives is worth having with your glaucoma specialist.

Is laser treatment an option if my eyes cannot tolerate drops?

Yes. Selective laser trabeculoplasty (SLT) can lower IOP and reduce dependence on drops. For patients whose ocular surface disease is severe and driven by drop toxicity, reducing the drop burden through laser or surgery is a clinically sound strategy.

Internal Linking Architecture Statement

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma diagnosis, monitoring, and treatment. Please also read our Dry Eye Hub. Here’s another heartening patient story: Tired of glaucoma eyedrops.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Read More

Basics of Dry Eye, Dry Eye Second Opinion, Dry Eye: A Chronic Disease

Why Do Women Get Dry Eye More Often? Menopause and Dry Eye

Dry Eyes: Natural Remedies, Dry Eyes: Tips to Soothe Sore Eyes

Why Dry Eye Is Worse in Air Conditioning and on Flights

Screen Fatigue, Why Vision Becomes Blurred After Reading or Screen Use,

Why Your Eyes Water Constantly, Omega-3 and Dry Eye, Why Are Your Dry Eye Drops Not Working

Glaucoma Eye Drops: The Complete Guide, Laser or Eye Drops for Glaucoma

Managing Glaucoma Eye Drop Side Effects, Which Is the Best Eyedrop for Glaucoma?

Why Do I Need So Many Glaucoma Eye Drops?

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.

The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.

Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.

What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.

“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.

Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.

FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.

What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.

A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google